21148423

Source:http://linkedlifedata.com/resource/pubmed/id/21148423

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0005516, umls-concept:C0014257, umls-concept:C0038250, umls-concept:C0147139, umls-concept:C0302600, umls-concept:C0871161, umls-concept:C1704436
pubmed:issue	3
pubmed:dateCreated	2011-2-17
pubmed:databankReference	http://linkedlifedata.com/resource/pubmed/xref/ClinicalTrials.gov/NCT00377897
pubmed:abstractText	We examined whether plasma levels of angiogenic factors are altered in plasma of patients with peripheral arterial disease (PAD) and whether these factors affect endothelial progenitor cell-induced angiogenesis.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9505803
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Angiogenic Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD47, http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers, http://linkedlifedata.com/resource/pubmed/chemical/Chemokine CXCL12, http://linkedlifedata.com/resource/pubmed/chemical/Pregnancy Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, CXCR4, http://linkedlifedata.com/resource/pubmed/chemical/Thrombospondin 1, http://linkedlifedata.com/resource/pubmed/chemical/VEGFA protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A, http://linkedlifedata.com/resource/pubmed/chemical/placenta growth factor
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	1524-4636
pubmed:author	pubmed-author:BiècheIvanI, pubmed-author:Boisson-VidalCatherineC, pubmed-author:BrunevalPatrickP, pubmed-author:DiasJuliana-VieiraJV, pubmed-author:Dignat-GeorgeFrançoiseF, pubmed-author:DizierBlandineB, pubmed-author:Duong-Van-HuyenJean-PaulJP, pubmed-author:EmmerichJosephJ, pubmed-author:EvrardSolèneS, pubmed-author:GaussemPascaleP, pubmed-author:LabreucheJulienJ, pubmed-author:LaurendeauIngridI, pubmed-author:MarsacBérengèreB, pubmed-author:MaugeLaetitiaL, pubmed-author:MorandiVerônicaV, pubmed-author:SmadjaDavid MDM, pubmed-author:Wagner-BallonOrianneO, pubmed-author:d'AudigierClémentC
pubmed:issnType	Electronic
pubmed:volume	31
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	551-9
pubmed:meshHeading	pubmed-meshheading:21148423-Angiogenic Proteins, pubmed-meshheading:21148423-Animals, pubmed-meshheading:21148423-Antigens, CD47, pubmed-meshheading:21148423-Biological Markers, pubmed-meshheading:21148423-Case-Control Studies, pubmed-meshheading:21148423-Cell Adhesion, pubmed-meshheading:21148423-Cell Proliferation, pubmed-meshheading:21148423-Cells, Cultured, pubmed-meshheading:21148423-Chemokine CXCL12, pubmed-meshheading:21148423-Disease Models, Animal, pubmed-meshheading:21148423-Endothelial Cells, pubmed-meshheading:21148423-Hindlimb, pubmed-meshheading:21148423-Humans, pubmed-meshheading:21148423-Ischemia, pubmed-meshheading:21148423-Mice, pubmed-meshheading:21148423-Mice, Inbred C57BL, pubmed-meshheading:21148423-Mice, Knockout, pubmed-meshheading:21148423-Muscle, Skeletal, pubmed-meshheading:21148423-Neovascularization, Physiologic, pubmed-meshheading:21148423-Peripheral Arterial Disease, pubmed-meshheading:21148423-Phenotype, pubmed-meshheading:21148423-Pregnancy Proteins, pubmed-meshheading:21148423-RNA Interference, pubmed-meshheading:21148423-Receptors, CXCR4, pubmed-meshheading:21148423-Stem Cell Transplantation, pubmed-meshheading:21148423-Stem Cells, pubmed-meshheading:21148423-Thrombospondin 1, pubmed-meshheading:21148423-Treatment Outcome, pubmed-meshheading:21148423-Vascular Endothelial Growth Factor A
pubmed:year	2011
pubmed:articleTitle	Thrombospondin-1 is a plasmatic marker of peripheral arterial disease that modulates endothelial progenitor cell angiogenic properties.
pubmed:affiliation	Université Paris Descartes, Paris, France. david.smadja@egp.aphp.fr
pubmed:publicationType	Journal Article, Controlled Clinical Trial, Research Support, Non-U.S. Gov't, Clinical Trial, Phase I